Human ECT

Our electroporators allow us to treat benign skin tumors and local neoplasms also in humans. In this regard, the Biopulse Biotech research group,  have carried out several studies and scientific collaborations. For example, the pilot prospective study on the successful treatment of plantar warts with intralesional bleomycin and electroporation. The study was completed with the Department of Dermatology of the Pius Hospital de Valls, Spain. Scientific director of the project was Dr. Paola Pasquali, doctor and scientist specializing in applications of physical therapy in dermatology. The study’s cohort included 12 men and 10 women, with a mean age of 53.8 years. A total of 22 warts were treated. In dividing the patients in two groups (complete remission against all the others) and analyzing the different outcomes in the two arms of patients, a statistical significant difference was found (p=0.0015), proving a greater efficacy of the treatment with bleomycin combined with ECT as opposed to bleomycin alone. Electroporation was always well tolerated by the patients with no discomfort.  This study serves as a basis for the application of novel protocols in the treatment of different benign and locally malignant skin lesion by means of electroporation. The study was registered in the Spanish Ministry of Health with the number 2014-003339-21.